Cresco Labs (CRLBF) FCF Payout Ratio (2020 - 2025)
Cresco Labs (CRLBF) posted FCF Payout Ratio of 2.95 for Q1 2025, up 76.27% on a QoQ basis from 12.44 in Q1 2024, and up 76.27% year-over-year from 1.67 in Q1 2024.
Cresco Labs (CRLBF) FCF Payout Ratio (2020 - 2025) Analysis & Trends
Cresco Labs' FCF Payout Ratio history runs 3 years deep, the most recent figure standing at 2.95 for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.77 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -10.50 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.40 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.95 |
| Mar 31, 2024 | -12.44 |
| Dec 31, 2020 | 0.00 |